Stock CSBR CHAMPIONS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Market Closed - Nasdaq
Other stock markets
 21:30:00 27/06/2024 BST 		5-day change 1st Jan Change
5.05 USD +1.81% Intraday chart for Champions Oncology, Inc. +4.55% -10.14%
06-04 Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development CI
03-15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
CI
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
CI
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
CI
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
CI
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023
CI
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023
CI
Champions Oncology Forms Therapeutic Discovery Platform Unit Corellia AI
MT
Champions Oncology, Inc. announces an Equity Buyback for $5 million worth of its shares.
CI
Champions Oncology, Inc. authorizes a Buyback Plan.
CI
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023
CI
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023
CI
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022
CI
Champions Oncology, Inc. Provides Revenue Guidance for the Fiscal Year 2023
CI
Champions Oncology Q2 EPS Declines, Revenue Rises to Record Level
MT
Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Posts Q2 EPS $0.01
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. News Champions Oncology, Inc.
  5. Highlights